ABBOTT LABORATORIES (ABT) Operating cash flow 2016–2025
ABBOTT LABORATORIES (ABT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$9.6BFY2025 · since FY2016: $3.2B → $9.6B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $9.6B | +11.8% |
| FY2024 | $8.6B | +17.9% |
| FY2023 | $7.3B | -24.2% |
| FY2022 | $9.6B | -9.0% |
| FY2021 | $10.5B | +33.3% |
| FY2020 | $7.9B | +28.8% |
| FY2019 | $6.1B | -2.6% |
| FY2018 | $6.3B | +13.1% |
| FY2017 | $5.6B | +73.9% |
| FY2016 | $3.2B | — |
Source: SEC XBRL filings · For reference only · Not investment advice